The downregulation of miR-486-5p is found in lung tissues of IPF patients, and its overexpression in mouse models reduces lung fibrosis through targeting SMAD2, a crucial mediator of pulmonary fibrosis and implicated in TGF-β1 signaling (Ji et al., 2015). Here, SMAD2 is linked to idiopathic pulmonary fibrosis.